A Randomized Pilot Cognitive Behavioral Sleep Health Trial for Young Adults with Type 1 Diabetes
Abstract
Objectives: The purpose of this randomized controlled trial was to determine whether a cognitive-behavioral sleep health self-management intervention (CB-Sleep Health) would be more effective than a time-balanced attention control (AC) condition in improving multiple dimensions of sleep health (self-reported and objectively derived).
Methods: Young adults with T1D (ages 18-26 years) were randomly assigned to a 12-week CB-Sleep Health (n = 21) or AC condition (n = 18). They wore concurrent continuous glucose monitors and actigraphy devices and completed daily sleep surveys for 14 days at baseline, post-intervention, and 3-month follow-up.
Results: Of the randomized participants, 31 (79.5%) completed the post-intervention, while 33 (84.6%) completed the 3-month follow-up. The CB-Sleep Health intervention had a significant effect on alertness and duration compared to the control group. The changes from baseline were -3.21 s vs. +0.71, p = .005 and +18 min vs. -25.8 min, p = .01, respectively. These effects were sustained at the 3-month follow-up.
Conclusions: Longer sleep duration, higher daytime alertness, and sustained sleep efficiency are possible with this CB-Sleep Health intervention in young adults managing a complex condition.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 21 participants or records.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.